Drug Shortage Report for GAMMAGARD S/D

Last updated on 2024-01-31 History
Report ID 207306
Drug Identification Number 02231470
Brand name GAMMAGARD S/D
Common or Proper name Immunoglobulin Intravenous (Human)
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) IMMUNOGLOBULIN
Strength(s) 5G
Dosage form(s) KIT SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 100 mL Vial
ATC code J06BA
ATC description IMMUNOGLOBULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-12-15
Actual start date
Estimated end date 2024-04-30
Actual end date 2024-01-29
Shortage status Resolved
Updated date 2024-01-31
Company comments Shortage related to the disruption in supply of co-packaged sterile Water for Injection and not related to the immunoglobulin drug product.
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-01-31 English Compare
v15 2023-12-16 English Compare
v14 2023-10-18 French Compare
v13 2023-10-18 English Compare
v12 2023-10-18 French Compare
v11 2023-10-18 English Compare
v10 2023-10-18 French Compare
v9 2023-10-18 English Compare
v8 2023-10-18 French Compare
v7 2023-10-18 English Compare
v6 2023-10-18 French Compare
v5 2023-10-18 English Compare
v4 2023-10-18 French Compare
v3 2023-10-18 English Compare
v2 2023-10-18 French Compare
v1 2023-10-18 English Compare

Showing 1 to 16 of 16